Comorbidities included hypertensive diseases (I10-I16), Type 2 diabetes mellitus (E11), chronic lower respiratory diseases (J40-J47), neoplasms (C00-D49), psychoactive substance use (F10-F19), ischemic heart diseases (I20-I25), chronic kidney disease (N18), and cerebrovascular diseases (I60-I69)
Safe, Proven Results with GLP-1 Injections: Semaglutide and Tirzepatide (GLP-1 medications) are clinically proven to reduce hunger, improve insulin sensitivity, and support sustainable fat loss
If we want to allow for these potentially miracle peptides to be available to the mainstream we must figure out a way to do it in a more responsible way
Maple Research Labs ships BPC-157 peptide Canada orders same-day from our Canadian facility
Calories: ~340370 Protein: ~2530g GLP-1 Tip: Oats can feel heavy smaller amounts work better which is why we included only 2 tbsp